search
Back to results

Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)

Primary Purpose

Irritable Bowel Syndrome

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Eluxadoline
Placebo
Sponsored by
Furiex Pharmaceuticals, Inc
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Irritable Bowel Syndrome

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Participant has a diagnosis of irritable bowel syndrome (IBS) with a subtype of diarrhea defined by the Rome III criteria.
  2. Participant has had a colonoscopy performed:

    • Within 10 years prior to Prescreening if participant is at least 50 years of age (sigmoidoscopy, double contrast barium enema, or computed tomography (CT) colonography within the past 5 years is acceptable)
    • Since the onset (if applicable) of any of the following alarm features for participants of any age:

      • Participant has documented weight loss within the past 6 months
      • Participant has nocturnal symptoms
      • Participant has a familial history of first-degree relatives with colon cancer or
      • Participant has blood mixed with their stool (excluding blood from hemorrhoids).
  3. Female participants must be:

    • Postmenopausal, defined as 52 years or older and amenorrheic for at least 2 years at Prescreening,
    • Surgically sterile (have had a hysterectomy or bilateral oophorectomy, tubal ligation, or otherwise be incapable of pregnancy),
    • Abstinent, or
    • If sexually active, be practicing an effective method of birth control.

Exclusion Criteria:

  1. Participant has a diagnosis of IBS with a subtype of constipation, mixed IBS, or unsubtyped IBS by the Rome III criteria.
  2. Participant has a history of inflammatory or immune-mediated gastrointestinal (GI) disorders including inflammatory bowel disease (ie, Crohn's disease, ulcerative colitis) and celiac disease.
  3. Participant has a history of diverticulitis within 3 months prior to Prescreening.
  4. Participant has a history of intestinal obstruction, stricture, toxic megacolon, GI perforation, fecal impaction, gastric banding, bariatric surgery, adhesions, ischemic colitis, or impaired intestinal circulation (eg, aortoiliac disease).
  5. Participant has any of the following surgical history:

    • Cholecystectomy with any history of post cholecystectomy biliary tract pain
    • Any abdominal surgery within the 3 months prior to Prescreening
    • Participant has a history of major gastric, hepatic, pancreatic, or intestinal surgery (appendectomy, hemorrhoidectomy, or polypectomy greater than 3 months post surgery are allowed)

Other protocol-specific eligibility criteria may apply.

Sites / Locations

  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furix Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site
  • Furiex Research Site

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Placebo Comparator

Arm Label

Eluxadoline 75 mg

Eluxadoline 100 mg

Placebo

Arm Description

Eluxadoline 75 mg tablets, orally, twice daily for up to 52 weeks period.

Eluxadoline 100 mg tablets, orally, twice daily for up to 52 weeks period.

Eluxadoline placebo matching tablets, orally, twice daily for up to 52 weeks period.

Outcomes

Primary Outcome Measures

Percentage of Participants Who Were Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain And Daily Stool Consistency Scores
Composite responders were defined as a participant who met the daily response criteria for at least 50% of the days with diary entries during the interval of interest. A participant must had met both of the following criteria on a given day to be a daily responder: 1) Daily pain response: worst abdominal pain scores in the past 24 hours improved by ≥30% compared to baseline (average of daily worst abdominal pain the week prior to randomization). 2) Daily stool consistency response: Bristol Stool Scale (BSS) score <5 (ie, score of 1, 2, 3, or 4) or the absence of a bowel movement if accompanied by ≥30% improvement in worst abdominal pain compared to baseline pain. Bristol stool scale was defined as 7-point Scale in which a score of 1 = separate hard lumps, 2 = sausage shaped but lumpy, 3 = sausage-like with cracks on the surface, 4 = sausage-like but smooth and soft, 5 = soft blobs with clear cut edges, 6 = fluffy pieces with ragged edges, and 7 = watery with no solid pieces.

Secondary Outcome Measures

Percentage of Participants Who Were Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain And Daily Stool Consistency Scores
Composite responders were defined as a participant who met the daily response criteria for at least 50% of the days with diary entries during the interval of interest. A participant must had met both of the following criteria on a given day to be a daily responder: 1) Daily pain response: worst abdominal pain scores in the past 24 hours improved by ≥30% compared to baseline (average of daily worst abdominal pain the week prior to randomization). 2) Daily stool consistency response: Bristol Stool Scale (BSS) score <5 (ie, score of 1, 2, 3, or 4) or the absence of a bowel movement if accompanied by ≥30% improvement in worst abdominal pain compared to baseline pain. Bristol stool scale was defined as 7-point Scale in which a score of 1 = separate hard lumps, 2 = sausage shaped but lumpy, 3 = sausage-like with cracks on the surface, 4 = sausage-like but smooth and soft, 5 = soft blobs with clear cut edges, 6 = fluffy pieces with ragged edges, and 7 = watery with no solid pieces.
Percentage of Participants Who Were Pain Responders In Daily Worst Abdominal Pain Scores by Intervals
Pain responders were defined as participants who met the daily pain response criteria (ie, the worst abdominal pain score in the past 24 hours improved by ≥30% compared to baseline) for at least 50% of days with diary entries during each interval. A participant must have had a minimum of 20 days of diary entries over any 4-week interval, a minimum of 60 days of diary entries over the 12-week interval, and a minimum of 110 days of diary entries over the 26-week interval to be a responder.
Percentage of Participants Who Were Responders In Daily Stool Consistency Scores by Intervals
Stool consistency responders: participants who met daily stool consistency response criterion (ie,score of 1, 2, 3, or 4 or absence of bowel movement if accompanied by ≥30% improvement in worst abdominal pain compared to baseline pain) for at least 50% of days with diary entries during each interval. BSS was defined as 7-point Scale in which score of 1= separate hard lumps, 2= sausage shaped but lumpy, 3= sausage-like with cracks on the surface, 4= sausage-like but smooth and soft, 5= soft blobs with clear cut edges, 6= fluffy pieces with ragged edges, and 7= watery with no solid pieces. A participant must have had a minimum of 20 days of diary entries over any 4-week interval, a minimum of 60 days of diary entries over 12-week interval, and a minimum of 110 days of diary entries over 26-week interval to be a responder.
Percentage of Participants Who Were Responders In Irritable Bowel Syndrome, Diarrhea Predominant (IBS-d) Global Symptom Scale by Intervals
IBS-d global symptom responders were defined as those participants who met the daily IBS-d global symptom response criteria (ie, IBS-d global symptom score of 0 [none] or 1 [mild]; or a daily IBS-d global symptom score improved by ≥2.0 compared to the baseline average) for at least 50% of days with diary entries during each interval. IBS-d Global Symptom Scale was a 5 point scale, score ranging from 0 to 4. 0= no symptoms, 1= mild symptoms, 2= moderate symptoms, 3= severe symptoms and 4 = very severe symptoms. A participant must have had a minimum of 20 days of diary entries over any 4-week interval, a minimum of 60 days of diary entries over the 12-week interval, and a minimum of 110 days of diary entries over the 26-week interval to be a responder.
Percentage of Participants Who Were Responders to the Irritable Bowel Syndrome Quality of Life Measure (IBS-QoL) Scale
IBS-QoL responders were defined as participants who achieved at least a 14-point improvement in IBS-QoL total score from baseline to the applicable visit. The IBS-QoL consists of 34 items each with a 5-point response scale, where 1 generally represents better responses on items and 5 represents worse responses. The individual responses to the answered items were summed and standardized for a total score and then transformed to a 0- to 100-point (0= worst; 100=better) scale for ease of interpretation.
Percentage of Participants With Irritable Bowel Syndrome - Adequate Relief (IBS-AR) Scale
Adequate relief of IBS symptoms was assessed once weekly by participants answering the IBS-AR item in the electronic diary. IBS-AR responders were defined as participants with a weekly response of "Yes" to adequate relief of their IBS symptoms for at least 50% of the total weeks during the interval. A participant must have had a positive response on ≥6 weeks for the 12-week interval and ≥13 weeks for the 26-week interval, regardless of diary compliance, to be a responder.
Change From Baseline in Daily Abdominal Discomfort Scores
Symptoms of abdominal discomfort were recorded on a 0 to 10 scale, where 0 corresponded to no discomfort and 10 corresponded to worst imaginable discomfort. A negative change from Baseline indicates the discomfort decreased.
Change From Baseline in Daily Abdominal Bloating Scores
Symptoms of abdominal bloating were recorded on a 0 to 10 scale, where 0 corresponded to no bloating and 10 corresponded to worst imaginable bloating. A negative change from Baseline indicates the bloating decreased.
Number of Bowel Movements Per Day
Participants recorded the number of bowel movements over 24 hours daily throughout the treatment.
Number of Bowel Incontinence Episodes
Participants recorded the number of incontinence episodes over 24 hours daily throughout the treatment.
Number of Bowel Incontinence Free Days
An incontinence free day was one where the participant reports zero incontinence episodes. The number of incontinence free days for a participant was assessed each week based on the number of reported days.
Number of Urgency Episodes Per Day
Participants recorded the number of urgency episodes over 24 hours daily throughout the treatment.
IBS-QoL Total Scores
The IBS-QoL consists of 34 items each with a 5-point response scale, where 1 generally represents better responses on items and 5 represents worse responses. The individual responses to the answered items were summed and standardized for a total score and then transformed to a 0- to 100- point scale (0=worst; 100=better) for ease of interpretation.
Change From Baseline in IBS-QoL Total Scores
The IBS-QoL consists of 34 items each with a 5-point response scale, where 1 generally represents better responses on items and 5 represents worse responses. The individual responses to the answered items were summed and standardized for a total score and then transformed to a 0- to 100- point scale (0=worst; 100=better) for ease of interpretation. A positive change from Baseline indicates that quality of life improved.

Full Information

First Posted
March 8, 2012
Last Updated
August 3, 2018
Sponsor
Furiex Pharmaceuticals, Inc
search

1. Study Identification

Unique Protocol Identification Number
NCT01553591
Brief Title
Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)
Official Title
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
May 29, 2012 (Actual)
Primary Completion Date
July 29, 2014 (Actual)
Study Completion Date
July 29, 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Furiex Pharmaceuticals, Inc

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine the efficacy, safety, and tolerability of different doses of eluxadoline (JNJ-27018966) compared with placebo in the treatment of participants with diarrhea-predominant irritable bowel syndrome.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Irritable Bowel Syndrome

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
1282 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Eluxadoline 75 mg
Arm Type
Experimental
Arm Description
Eluxadoline 75 mg tablets, orally, twice daily for up to 52 weeks period.
Arm Title
Eluxadoline 100 mg
Arm Type
Experimental
Arm Description
Eluxadoline 100 mg tablets, orally, twice daily for up to 52 weeks period.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Eluxadoline placebo matching tablets, orally, twice daily for up to 52 weeks period.
Intervention Type
Drug
Intervention Name(s)
Eluxadoline
Other Intervention Name(s)
JNJ-27018966
Intervention Description
Oral tablets twice daily
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Oral tablets twice daily
Primary Outcome Measure Information:
Title
Percentage of Participants Who Were Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain And Daily Stool Consistency Scores
Description
Composite responders were defined as a participant who met the daily response criteria for at least 50% of the days with diary entries during the interval of interest. A participant must had met both of the following criteria on a given day to be a daily responder: 1) Daily pain response: worst abdominal pain scores in the past 24 hours improved by ≥30% compared to baseline (average of daily worst abdominal pain the week prior to randomization). 2) Daily stool consistency response: Bristol Stool Scale (BSS) score <5 (ie, score of 1, 2, 3, or 4) or the absence of a bowel movement if accompanied by ≥30% improvement in worst abdominal pain compared to baseline pain. Bristol stool scale was defined as 7-point Scale in which a score of 1 = separate hard lumps, 2 = sausage shaped but lumpy, 3 = sausage-like with cracks on the surface, 4 = sausage-like but smooth and soft, 5 = soft blobs with clear cut edges, 6 = fluffy pieces with ragged edges, and 7 = watery with no solid pieces.
Time Frame
Up to 12 Weeks
Secondary Outcome Measure Information:
Title
Percentage of Participants Who Were Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain And Daily Stool Consistency Scores
Description
Composite responders were defined as a participant who met the daily response criteria for at least 50% of the days with diary entries during the interval of interest. A participant must had met both of the following criteria on a given day to be a daily responder: 1) Daily pain response: worst abdominal pain scores in the past 24 hours improved by ≥30% compared to baseline (average of daily worst abdominal pain the week prior to randomization). 2) Daily stool consistency response: Bristol Stool Scale (BSS) score <5 (ie, score of 1, 2, 3, or 4) or the absence of a bowel movement if accompanied by ≥30% improvement in worst abdominal pain compared to baseline pain. Bristol stool scale was defined as 7-point Scale in which a score of 1 = separate hard lumps, 2 = sausage shaped but lumpy, 3 = sausage-like with cracks on the surface, 4 = sausage-like but smooth and soft, 5 = soft blobs with clear cut edges, 6 = fluffy pieces with ragged edges, and 7 = watery with no solid pieces.
Time Frame
Up to 26 Weeks
Title
Percentage of Participants Who Were Pain Responders In Daily Worst Abdominal Pain Scores by Intervals
Description
Pain responders were defined as participants who met the daily pain response criteria (ie, the worst abdominal pain score in the past 24 hours improved by ≥30% compared to baseline) for at least 50% of days with diary entries during each interval. A participant must have had a minimum of 20 days of diary entries over any 4-week interval, a minimum of 60 days of diary entries over the 12-week interval, and a minimum of 110 days of diary entries over the 26-week interval to be a responder.
Time Frame
12-week interval (Weeks 1-12), 26-week interval (Weeks 1-26), and 4-week interval (Weeks 1-4, 5-8, 9-12, 13-16, 17-20, and 21-24)
Title
Percentage of Participants Who Were Responders In Daily Stool Consistency Scores by Intervals
Description
Stool consistency responders: participants who met daily stool consistency response criterion (ie,score of 1, 2, 3, or 4 or absence of bowel movement if accompanied by ≥30% improvement in worst abdominal pain compared to baseline pain) for at least 50% of days with diary entries during each interval. BSS was defined as 7-point Scale in which score of 1= separate hard lumps, 2= sausage shaped but lumpy, 3= sausage-like with cracks on the surface, 4= sausage-like but smooth and soft, 5= soft blobs with clear cut edges, 6= fluffy pieces with ragged edges, and 7= watery with no solid pieces. A participant must have had a minimum of 20 days of diary entries over any 4-week interval, a minimum of 60 days of diary entries over 12-week interval, and a minimum of 110 days of diary entries over 26-week interval to be a responder.
Time Frame
12-week interval (Weeks 1-12), 26-week interval (Weeks 1-26), and 4-week interval (Weeks 1-4, 5-8, 9-12, 13-16, 17-20, and 21-24)
Title
Percentage of Participants Who Were Responders In Irritable Bowel Syndrome, Diarrhea Predominant (IBS-d) Global Symptom Scale by Intervals
Description
IBS-d global symptom responders were defined as those participants who met the daily IBS-d global symptom response criteria (ie, IBS-d global symptom score of 0 [none] or 1 [mild]; or a daily IBS-d global symptom score improved by ≥2.0 compared to the baseline average) for at least 50% of days with diary entries during each interval. IBS-d Global Symptom Scale was a 5 point scale, score ranging from 0 to 4. 0= no symptoms, 1= mild symptoms, 2= moderate symptoms, 3= severe symptoms and 4 = very severe symptoms. A participant must have had a minimum of 20 days of diary entries over any 4-week interval, a minimum of 60 days of diary entries over the 12-week interval, and a minimum of 110 days of diary entries over the 26-week interval to be a responder.
Time Frame
12-week interval (Weeks 1-12), 26-week interval (Weeks 1-26), and 4-week interval (Weeks 1-4, 5-8, 9-12, 13-16, 17-20, and 21-24)
Title
Percentage of Participants Who Were Responders to the Irritable Bowel Syndrome Quality of Life Measure (IBS-QoL) Scale
Description
IBS-QoL responders were defined as participants who achieved at least a 14-point improvement in IBS-QoL total score from baseline to the applicable visit. The IBS-QoL consists of 34 items each with a 5-point response scale, where 1 generally represents better responses on items and 5 represents worse responses. The individual responses to the answered items were summed and standardized for a total score and then transformed to a 0- to 100-point (0= worst; 100=better) scale for ease of interpretation.
Time Frame
Weeks 4, 8, 12, 18, 26, 36, 44, and 52 (End of Treatment [EOT])
Title
Percentage of Participants With Irritable Bowel Syndrome - Adequate Relief (IBS-AR) Scale
Description
Adequate relief of IBS symptoms was assessed once weekly by participants answering the IBS-AR item in the electronic diary. IBS-AR responders were defined as participants with a weekly response of "Yes" to adequate relief of their IBS symptoms for at least 50% of the total weeks during the interval. A participant must have had a positive response on ≥6 weeks for the 12-week interval and ≥13 weeks for the 26-week interval, regardless of diary compliance, to be a responder.
Time Frame
12-week interval (Weeks 1-12) and 26-week interval (Weeks 1-26)
Title
Change From Baseline in Daily Abdominal Discomfort Scores
Description
Symptoms of abdominal discomfort were recorded on a 0 to 10 scale, where 0 corresponded to no discomfort and 10 corresponded to worst imaginable discomfort. A negative change from Baseline indicates the discomfort decreased.
Time Frame
Baseline, Weeks 4, 12 and 26
Title
Change From Baseline in Daily Abdominal Bloating Scores
Description
Symptoms of abdominal bloating were recorded on a 0 to 10 scale, where 0 corresponded to no bloating and 10 corresponded to worst imaginable bloating. A negative change from Baseline indicates the bloating decreased.
Time Frame
Baseline, Weeks 4, 12 and 26
Title
Number of Bowel Movements Per Day
Description
Participants recorded the number of bowel movements over 24 hours daily throughout the treatment.
Time Frame
Weeks 4, 12 and 26
Title
Number of Bowel Incontinence Episodes
Description
Participants recorded the number of incontinence episodes over 24 hours daily throughout the treatment.
Time Frame
Weeks 4, 12 and 26
Title
Number of Bowel Incontinence Free Days
Description
An incontinence free day was one where the participant reports zero incontinence episodes. The number of incontinence free days for a participant was assessed each week based on the number of reported days.
Time Frame
Weeks 4, 12 and 26
Title
Number of Urgency Episodes Per Day
Description
Participants recorded the number of urgency episodes over 24 hours daily throughout the treatment.
Time Frame
Weeks 4, 12 and 26
Title
IBS-QoL Total Scores
Description
The IBS-QoL consists of 34 items each with a 5-point response scale, where 1 generally represents better responses on items and 5 represents worse responses. The individual responses to the answered items were summed and standardized for a total score and then transformed to a 0- to 100- point scale (0=worst; 100=better) for ease of interpretation.
Time Frame
Weeks 4, 8, 12, 18, 26, 36, 44, and 52 (EOT)
Title
Change From Baseline in IBS-QoL Total Scores
Description
The IBS-QoL consists of 34 items each with a 5-point response scale, where 1 generally represents better responses on items and 5 represents worse responses. The individual responses to the answered items were summed and standardized for a total score and then transformed to a 0- to 100- point scale (0=worst; 100=better) for ease of interpretation. A positive change from Baseline indicates that quality of life improved.
Time Frame
Baseline, Weeks 4, 8, 12, 18, 26, 36, 44, and 52/EOT

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Participant has a diagnosis of irritable bowel syndrome (IBS) with a subtype of diarrhea defined by the Rome III criteria. Participant has had a colonoscopy performed: Within 10 years prior to Prescreening if participant is at least 50 years of age (sigmoidoscopy, double contrast barium enema, or computed tomography (CT) colonography within the past 5 years is acceptable) Since the onset (if applicable) of any of the following alarm features for participants of any age: Participant has documented weight loss within the past 6 months Participant has nocturnal symptoms Participant has a familial history of first-degree relatives with colon cancer or Participant has blood mixed with their stool (excluding blood from hemorrhoids). Female participants must be: Postmenopausal, defined as 52 years or older and amenorrheic for at least 2 years at Prescreening, Surgically sterile (have had a hysterectomy or bilateral oophorectomy, tubal ligation, or otherwise be incapable of pregnancy), Abstinent, or If sexually active, be practicing an effective method of birth control. Exclusion Criteria: Participant has a diagnosis of IBS with a subtype of constipation, mixed IBS, or unsubtyped IBS by the Rome III criteria. Participant has a history of inflammatory or immune-mediated gastrointestinal (GI) disorders including inflammatory bowel disease (ie, Crohn's disease, ulcerative colitis) and celiac disease. Participant has a history of diverticulitis within 3 months prior to Prescreening. Participant has a history of intestinal obstruction, stricture, toxic megacolon, GI perforation, fecal impaction, gastric banding, bariatric surgery, adhesions, ischemic colitis, or impaired intestinal circulation (eg, aortoiliac disease). Participant has any of the following surgical history: Cholecystectomy with any history of post cholecystectomy biliary tract pain Any abdominal surgery within the 3 months prior to Prescreening Participant has a history of major gastric, hepatic, pancreatic, or intestinal surgery (appendectomy, hemorrhoidectomy, or polypectomy greater than 3 months post surgery are allowed) Other protocol-specific eligibility criteria may apply.
Facility Information:
Facility Name
Furiex Research Site
City
Athens
State/Province
Alabama
ZIP/Postal Code
35611
Country
United States
Facility Name
Furiex Research Site
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35213
Country
United States
Facility Name
Furiex Research Site
City
Foley
State/Province
Alabama
ZIP/Postal Code
36535
Country
United States
Facility Name
Furiex Research Site
City
Huntsville
State/Province
Alabama
ZIP/Postal Code
35802
Country
United States
Facility Name
Furiex Research Site
City
Ozark
State/Province
Alabama
ZIP/Postal Code
36360
Country
United States
Facility Name
Furiex Research Site
City
Chandler
State/Province
Arizona
ZIP/Postal Code
85224
Country
United States
Facility Name
Furiex Research Site
City
Glendale
State/Province
Arizona
ZIP/Postal Code
85306
Country
United States
Facility Name
Furiex Research Site
City
Mesa
State/Province
Arizona
ZIP/Postal Code
85213
Country
United States
Facility Name
Furiex Research Site
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85018
Country
United States
Facility Name
Furiex Research Site
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85712
Country
United States
Facility Name
Furiex Research Site
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72211
Country
United States
Facility Name
Furiex Research Site
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72212
Country
United States
Facility Name
Furiex Research Site
City
North Little Rock
State/Province
Arkansas
ZIP/Postal Code
72117
Country
United States
Facility Name
Furiex Research Site
City
Azusa
State/Province
California
ZIP/Postal Code
91702
Country
United States
Facility Name
Furiex Research Site
City
Bell Gardens
State/Province
California
ZIP/Postal Code
90201
Country
United States
Facility Name
Furiex Research Site
City
Beverly Hills
State/Province
California
ZIP/Postal Code
90211
Country
United States
Facility Name
Furiex Research Site
City
Carson
State/Province
California
ZIP/Postal Code
91105
Country
United States
Facility Name
Furiex Research Site
City
Chula Vista
State/Province
California
ZIP/Postal Code
91910
Country
United States
Facility Name
Furiex Research Site
City
Corona
State/Province
California
ZIP/Postal Code
92880
Country
United States
Facility Name
Furiex Research Site
City
El Cajon
State/Province
California
ZIP/Postal Code
92020
Country
United States
Facility Name
Furiex Research Site
City
Encino
State/Province
California
ZIP/Postal Code
91436
Country
United States
Facility Name
Furiex Research Site
City
Garden Grove
State/Province
California
ZIP/Postal Code
92843
Country
United States
Facility Name
Furiex Research Site
City
Lomita
State/Province
California
ZIP/Postal Code
90717
Country
United States
Facility Name
Furiex Research Site
City
Los Angeles
State/Province
California
ZIP/Postal Code
90022
Country
United States
Facility Name
Furiex Research Site
City
Monterey Park
State/Province
California
ZIP/Postal Code
91754
Country
United States
Facility Name
Furiex Research Site
City
Murrieta
State/Province
California
ZIP/Postal Code
92562
Country
United States
Facility Name
Furiex Research Site
City
Newport Beach
State/Province
California
ZIP/Postal Code
92663
Country
United States
Facility Name
Furiex Research Site
City
North Hollywood
State/Province
California
ZIP/Postal Code
91606
Country
United States
Facility Name
Furiex Research Site
City
Oakland
State/Province
California
ZIP/Postal Code
94612
Country
United States
Facility Name
Furiex Research Site
City
Oxnard
State/Province
California
ZIP/Postal Code
93030
Country
United States
Facility Name
Furiex Research Site
City
Pismo Beach
State/Province
California
ZIP/Postal Code
93449
Country
United States
Facility Name
Furiex Research Site
City
Poway
State/Province
California
ZIP/Postal Code
92064
Country
United States
Facility Name
Furiex Research Site
City
Riverside
State/Province
California
ZIP/Postal Code
92501
Country
United States
Facility Name
Furiex Research Site
City
Roseville
State/Province
California
ZIP/Postal Code
95661
Country
United States
Facility Name
Furiex Research Site
City
Sacramento
State/Province
California
ZIP/Postal Code
95825
Country
United States
Facility Name
Furiex Research Site
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States
Facility Name
Furiex Research Site
City
San Diego
State/Province
California
ZIP/Postal Code
92114
Country
United States
Facility Name
Furiex Research Site
City
Santa Monica
State/Province
California
ZIP/Postal Code
90404
Country
United States
Facility Name
Furiex Research Site
City
Thousand Oaks
State/Province
California
ZIP/Postal Code
91360
Country
United States
Facility Name
Furiex Research Site
City
Colorado Springs
State/Province
Colorado
ZIP/Postal Code
80904
Country
United States
Facility Name
Furiex Research Site
City
Colorado Springs
State/Province
Colorado
ZIP/Postal Code
80907
Country
United States
Facility Name
Furiex Research Site
City
Lafayette
State/Province
Colorado
ZIP/Postal Code
80026
Country
United States
Facility Name
Furiex Research Site
City
Lakewood
State/Province
Colorado
ZIP/Postal Code
80215
Country
United States
Facility Name
Furiex Research Site
City
Longmont
State/Province
Colorado
ZIP/Postal Code
80501
Country
United States
Facility Name
Furiex Research Site
City
Norwalk
State/Province
Connecticut
ZIP/Postal Code
06851
Country
United States
Facility Name
Furiex Research Site
City
Ridgefield
State/Province
Connecticut
ZIP/Postal Code
06877
Country
United States
Facility Name
Furiex Research Site
City
Boca Raton
State/Province
Florida
ZIP/Postal Code
33428
Country
United States
Facility Name
Furiex Research Site
City
Brandon
State/Province
Florida
ZIP/Postal Code
33511
Country
United States
Facility Name
Furiex Research Site
City
Clearwater
State/Province
Florida
ZIP/Postal Code
33765
Country
United States
Facility Name
Furiex Research Site
City
Cooper City
State/Province
Florida
ZIP/Postal Code
33024
Country
United States
Facility Name
Furiex Research Site
City
Coral Springs
State/Province
Florida
ZIP/Postal Code
33065
Country
United States
Facility Name
Furiex Research Site
City
Crystal River
State/Province
Florida
ZIP/Postal Code
34429
Country
United States
Facility Name
Furiex Research Site
City
Doral
State/Province
Florida
ZIP/Postal Code
33172
Country
United States
Facility Name
Furiex Research Site
City
Eustis
State/Province
Florida
ZIP/Postal Code
32726
Country
United States
Facility Name
Furix Research Site
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33013
Country
United States
Facility Name
Furiex Research Site
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Facility Name
Furiex Research Site
City
Inverness
State/Province
Florida
ZIP/Postal Code
34452
Country
United States
Facility Name
Furiex Research Site
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32216
Country
United States
Facility Name
Furiex Research Site
City
Kissimmee
State/Province
Florida
ZIP/Postal Code
34741
Country
United States
Facility Name
Furiex Research Site
City
Maitland
State/Province
Florida
ZIP/Postal Code
32751
Country
United States
Facility Name
Furiex Research Site
City
Melbourne
State/Province
Florida
ZIP/Postal Code
32935
Country
United States
Facility Name
Furiex Research Site
City
Miami Springs
State/Province
Florida
ZIP/Postal Code
33166
Country
United States
Facility Name
Furiex Research Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33015
Country
United States
Facility Name
Furiex Research Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33125
Country
United States
Facility Name
Furiex Research Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33126
Country
United States
Facility Name
Furiex Research Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33133
Country
United States
Facility Name
Furiex Research Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33135
Country
United States
Facility Name
Furiex Research Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33144
Country
United States
Facility Name
Furiex Research Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33155
Country
United States
Facility Name
Furiex Research Site
City
Miami
State/Province
Florida
ZIP/Postal Code
33175
Country
United States
Facility Name
Furiex Research Site
City
Miramar
State/Province
Florida
ZIP/Postal Code
33025
Country
United States
Facility Name
Furiex Research Site
City
Naples
State/Province
Florida
ZIP/Postal Code
34102
Country
United States
Facility Name
Furiex Research Site
City
New Port Richey
State/Province
Florida
ZIP/Postal Code
34653
Country
United States
Facility Name
Furiex Research Site
City
New Smyrna Beach
State/Province
Florida
ZIP/Postal Code
32168
Country
United States
Facility Name
Furiex Research Site
City
Orlando
State/Province
Florida
ZIP/Postal Code
32801
Country
United States
Facility Name
Furiex Research Site
City
Orlando
State/Province
Florida
ZIP/Postal Code
32806
Country
United States
Facility Name
Furiex Research Site
City
Orlando
State/Province
Florida
ZIP/Postal Code
32819
Country
United States
Facility Name
Furiex Research Site
City
Ormond Beach
State/Province
Florida
ZIP/Postal Code
32174
Country
United States
Facility Name
Furiex Research Site
City
Oviedo
State/Province
Florida
ZIP/Postal Code
32765
Country
United States
Facility Name
Furiex Research Site
City
Palm Beach
State/Province
Florida
ZIP/Postal Code
33472
Country
United States
Facility Name
Furiex Research Site
City
Pinellas Park
State/Province
Florida
ZIP/Postal Code
33781
Country
United States
Facility Name
Furiex Research Site
City
Pinellas Park
State/Province
Florida
ZIP/Postal Code
33782
Country
United States
Facility Name
Furiex Research Site
City
Port Orange
State/Province
Florida
ZIP/Postal Code
32129
Country
United States
Facility Name
Furiex Research Site
City
Sanford
State/Province
Florida
ZIP/Postal Code
32771
Country
United States
Facility Name
Furiex Research Site
City
Sebastian
State/Province
Florida
ZIP/Postal Code
32958
Country
United States
Facility Name
Furiex Research Site
City
South Miami
State/Province
Florida
ZIP/Postal Code
33143
Country
United States
Facility Name
Furiex Research Site
City
Tampa
State/Province
Florida
ZIP/Postal Code
33606
Country
United States
Facility Name
Furiex Research Site
City
Tampa
State/Province
Florida
ZIP/Postal Code
33607
Country
United States
Facility Name
Furiex Research Site
City
Venice
State/Province
Florida
ZIP/Postal Code
34292
Country
United States
Facility Name
Furiex Research Site
City
Wellington
State/Province
Florida
ZIP/Postal Code
33414
Country
United States
Facility Name
Furiex Research Site
City
Winter Haven
State/Province
Florida
ZIP/Postal Code
33880
Country
United States
Facility Name
Furiex Research Site
City
Winter Park
State/Province
Florida
ZIP/Postal Code
32792
Country
United States
Facility Name
Furiex Research Site
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30338
Country
United States
Facility Name
Furiex Research Site
City
Blue Ridge
State/Province
Georgia
ZIP/Postal Code
30513
Country
United States
Facility Name
Furiex Research Site
City
Johns Creek
State/Province
Georgia
ZIP/Postal Code
30097
Country
United States
Facility Name
Furiex Research Site
City
Lilburn
State/Province
Georgia
ZIP/Postal Code
30047
Country
United States
Facility Name
Furiex Research Site
City
Oakwood
State/Province
Georgia
ZIP/Postal Code
30566
Country
United States
Facility Name
Furiex Research Site
City
Perry
State/Province
Georgia
ZIP/Postal Code
31069
Country
United States
Facility Name
Furiex Research Site
City
Snellville
State/Province
Georgia
ZIP/Postal Code
30078
Country
United States
Facility Name
Furiex Research Site
City
Eagle
State/Province
Idaho
ZIP/Postal Code
83616
Country
United States
Facility Name
Furiex Research Site
City
Addison
State/Province
Illinois
ZIP/Postal Code
60101
Country
United States
Facility Name
Furiex Research Site
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States
Facility Name
Furiex Research Site
City
Morton
State/Province
Illinois
ZIP/Postal Code
61550
Country
United States
Facility Name
Furiex Research Site
City
Brownsburg
State/Province
Indiana
ZIP/Postal Code
46112
Country
United States
Facility Name
Furiex Research Site
City
Evansville
State/Province
Indiana
ZIP/Postal Code
47714
Country
United States
Facility Name
Furiex Research Site
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46202
Country
United States
Facility Name
Furiex Research Site
City
Clive
State/Province
Iowa
ZIP/Postal Code
50325
Country
United States
Facility Name
Furiex Research Site
City
Davenport
State/Province
Iowa
ZIP/Postal Code
52807
Country
United States
Facility Name
Furiex Research Site
City
Iowa City
State/Province
Iowa
ZIP/Postal Code
52242
Country
United States
Facility Name
Furiex Research Site
City
West Des Moines
State/Province
Iowa
ZIP/Postal Code
50266
Country
United States
Facility Name
Furiex Research Site
City
Newton
State/Province
Kansas
ZIP/Postal Code
67114
Country
United States
Facility Name
Furiex Research Site
City
Prairie Village
State/Province
Kansas
ZIP/Postal Code
66206
Country
United States
Facility Name
Furiex Research Site
City
Shawnee Mission
State/Province
Kansas
ZIP/Postal Code
66218
Country
United States
Facility Name
Furiex Research Site
City
Wichita
State/Province
Kansas
ZIP/Postal Code
67203
Country
United States
Facility Name
Furiex Research Site
City
Wichita
State/Province
Kansas
ZIP/Postal Code
67205
Country
United States
Facility Name
Furiex Research Site
City
Crestview Hills
State/Province
Kentucky
ZIP/Postal Code
41017
Country
United States
Facility Name
Furiex Research Site
City
Hawesville
State/Province
Kentucky
ZIP/Postal Code
42348
Country
United States
Facility Name
Furiex Research Site
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40509
Country
United States
Facility Name
Furiex Research Site
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40536
Country
United States
Facility Name
Furiex Research Site
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40202
Country
United States
Facility Name
Furiex Research Site
City
Madisonville
State/Province
Kentucky
ZIP/Postal Code
42431
Country
United States
Facility Name
Furiex Research Site
City
Owensboro
State/Province
Kentucky
ZIP/Postal Code
42303
Country
United States
Facility Name
Furiex Research Site
City
Baker
State/Province
Louisiana
ZIP/Postal Code
70794
Country
United States
Facility Name
Furiex Research Site
City
Covington
State/Province
Louisiana
ZIP/Postal Code
70435
Country
United States
Facility Name
Furiex Research Site
City
Hammond
State/Province
Louisiana
ZIP/Postal Code
70403
Country
United States
Facility Name
Furiex Research Site
City
Metairie
State/Province
Louisiana
ZIP/Postal Code
70006
Country
United States
Facility Name
Furiex Research Site
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70124
Country
United States
Facility Name
Furiex Research Site
City
Opelousas
State/Province
Louisiana
ZIP/Postal Code
70570
Country
United States
Facility Name
Furiex Research Site
City
Shreveport
State/Province
Louisiana
ZIP/Postal Code
71101
Country
United States
Facility Name
Furiex Research Site
City
Shreveport
State/Province
Louisiana
ZIP/Postal Code
71105
Country
United States
Facility Name
Furiex Research Site
City
Bangor
State/Province
Maine
ZIP/Postal Code
04401
Country
United States
Facility Name
Furiex Research Site
City
Annapolis
State/Province
Maryland
ZIP/Postal Code
21401
Country
United States
Facility Name
Furiex Research Site
City
Chevy Chase
State/Province
Maryland
ZIP/Postal Code
20815
Country
United States
Facility Name
Furiex Research Site
City
Brockton
State/Province
Massachusetts
ZIP/Postal Code
02301
Country
United States
Facility Name
Furiex Research Site
City
Watertown
State/Province
Massachusetts
ZIP/Postal Code
02472
Country
United States
Facility Name
Furiex Research Site
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48106
Country
United States
Facility Name
Furiex Research Site
City
Southfield
State/Province
Michigan
ZIP/Postal Code
48034
Country
United States
Facility Name
Furiex Research Site
City
Stevensville
State/Province
Michigan
ZIP/Postal Code
49127
Country
United States
Facility Name
Furiex Research Site
City
Chaska
State/Province
Minnesota
ZIP/Postal Code
55318
Country
United States
Facility Name
Furiex Research Site
City
Jackson
State/Province
Mississippi
ZIP/Postal Code
39202
Country
United States
Facility Name
Furiex Research Site
City
Jefferson City
State/Province
Missouri
ZIP/Postal Code
65109
Country
United States
Facility Name
Furiex Research Site
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63128
Country
United States
Facility Name
Furiex Research Site
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63141
Country
United States
Facility Name
Furiex Research Site
City
Saint Peters
State/Province
Missouri
ZIP/Postal Code
63376
Country
United States
Facility Name
Furiex Research Site
City
Billings
State/Province
Montana
ZIP/Postal Code
59102
Country
United States
Facility Name
Furiex Research Site
City
Bellevue
State/Province
Nebraska
ZIP/Postal Code
68005
Country
United States
Facility Name
Furiex Research Site
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68114
Country
United States
Facility Name
Furiex Research Site
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68134
Country
United States
Facility Name
Furiex Research Site
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89106
Country
United States
Facility Name
Furiex Research Site
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89119
Country
United States
Facility Name
Furiex Research Site
City
Collingswood
State/Province
New Jersey
ZIP/Postal Code
08108
Country
United States
Facility Name
Furiex Research Site
City
Edison
State/Province
New Jersey
ZIP/Postal Code
08817
Country
United States
Facility Name
Furiex Research Site
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87106
Country
United States
Facility Name
Furiex Research Site
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11230
Country
United States
Facility Name
Furiex Research Site
City
Endwell
State/Province
New York
ZIP/Postal Code
13760
Country
United States
Facility Name
Furiex Research Site
City
Great Neck
State/Province
New York
ZIP/Postal Code
11023
Country
United States
Facility Name
Furiex Research Site
City
Hartsdale
State/Province
New York
ZIP/Postal Code
10530
Country
United States
Facility Name
Furiex Research Site
City
Kew Gardens
State/Province
New York
ZIP/Postal Code
11415
Country
United States
Facility Name
Furiex Research Site
City
New Windsor
State/Province
New York
ZIP/Postal Code
12553
Country
United States
Facility Name
Furiex Research Site
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
Facility Name
Furiex Research Site
City
North Massapequa
State/Province
New York
ZIP/Postal Code
11758
Country
United States
Facility Name
Furiex Research Site
City
Poughkeepsie
State/Province
New York
ZIP/Postal Code
12601
Country
United States
Facility Name
Furiex Research Site
City
Asheville
State/Province
North Carolina
ZIP/Postal Code
28801
Country
United States
Facility Name
Furiex Research Site
City
Asheville
State/Province
North Carolina
ZIP/Postal Code
28803
Country
United States
Facility Name
Furiex Research Site
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28211
Country
United States
Facility Name
Furiex Research Site
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27713
Country
United States
Facility Name
Furiex Research Site
City
Fayetteville
State/Province
North Carolina
ZIP/Postal Code
28304
Country
United States
Facility Name
Furiex Research Site
City
Greensboro
State/Province
North Carolina
ZIP/Postal Code
27403
Country
United States
Facility Name
Furiex Research Site
City
Hickory
State/Province
North Carolina
ZIP/Postal Code
28602
Country
United States
Facility Name
Furiex Research Site
City
High Point
State/Province
North Carolina
ZIP/Postal Code
27262
Country
United States
Facility Name
Furiex Research Site
City
Kinston
State/Province
North Carolina
ZIP/Postal Code
28501
Country
United States
Facility Name
Furiex Research Site
City
Lenoir
State/Province
North Carolina
ZIP/Postal Code
28645
Country
United States
Facility Name
Furiex Research Site
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27609
Country
United States
Facility Name
Furiex Research Site
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27612
Country
United States
Facility Name
Furiex Research Site
City
Salisbury
State/Province
North Carolina
ZIP/Postal Code
28144
Country
United States
Facility Name
Furiex Research Site
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27103
Country
United States
Facility Name
Furiex Research Site
City
Fargo
State/Province
North Dakota
ZIP/Postal Code
58103
Country
United States
Facility Name
Furiex Research Site
City
Fargo
State/Province
North Dakota
ZIP/Postal Code
58104
Country
United States
Facility Name
Furiex Research Site
City
Beavercreek
State/Province
Ohio
ZIP/Postal Code
45432
Country
United States
Facility Name
Furiex Research Site
City
Berea
State/Province
Ohio
ZIP/Postal Code
44017
Country
United States
Facility Name
Furiex Research Site
City
Centerville
State/Province
Ohio
ZIP/Postal Code
45459
Country
United States
Facility Name
Furiex Research Site
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45212
Country
United States
Facility Name
Furiex Research Site
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45219
Country
United States
Facility Name
Furiex Research Site
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43215
Country
United States
Facility Name
Furiex Research Site
City
Dayton
State/Province
Ohio
ZIP/Postal Code
45415
Country
United States
Facility Name
Furiex Research Site
City
Dayton
State/Province
Ohio
ZIP/Postal Code
45419
Country
United States
Facility Name
Furiex Research Site
City
Englewood
State/Province
Ohio
ZIP/Postal Code
45322
Country
United States
Facility Name
Furiex Research Site
City
Franklin
State/Province
Ohio
ZIP/Postal Code
45005
Country
United States
Facility Name
Furiex Research Site
City
Marion
State/Province
Ohio
ZIP/Postal Code
43302
Country
United States
Facility Name
Furiex Research Site
City
Miamisburg
State/Province
Ohio
ZIP/Postal Code
45342
Country
United States
Facility Name
Furiex Research Site
City
Middleburg Heights
State/Province
Ohio
ZIP/Postal Code
44130
Country
United States
Facility Name
Furiex Research Site
City
Wadsworth
State/Province
Ohio
ZIP/Postal Code
44281
Country
United States
Facility Name
Furiex Research Site
City
Zanesville
State/Province
Ohio
ZIP/Postal Code
43701
Country
United States
Facility Name
Furiex Research Site
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74104
Country
United States
Facility Name
Furiex Research Site
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74135
Country
United States
Facility Name
Furiex Research Site
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74136
Country
United States
Facility Name
Furiex Research Site
City
Belle Vernon
State/Province
Pennsylvania
ZIP/Postal Code
15012
Country
United States
Facility Name
Furiex Research Site
City
Jenkintown
State/Province
Pennsylvania
ZIP/Postal Code
19046
Country
United States
Facility Name
Furiex Research Site
City
Johnstown
State/Province
Pennsylvania
ZIP/Postal Code
15905
Country
United States
Facility Name
Furiex Research Site
City
Lansdale
State/Province
Pennsylvania
ZIP/Postal Code
19446
Country
United States
Facility Name
Furiex Research Site
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19142
Country
United States
Facility Name
Furiex Research Site
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19152
Country
United States
Facility Name
Furiex Research Site
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15236
Country
United States
Facility Name
Furiex Research Site
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15243
Country
United States
Facility Name
Furiex Research Site
City
Uniontown
State/Province
Pennsylvania
ZIP/Postal Code
15401
Country
United States
Facility Name
Furiex Research Site
City
Upper Saint Clair
State/Province
Pennsylvania
ZIP/Postal Code
15241
Country
United States
Facility Name
Furiex Research Site
City
Cumberland
State/Province
Rhode Island
ZIP/Postal Code
02864
Country
United States
Facility Name
Furiex Research Site
City
East Providence
State/Province
Rhode Island
ZIP/Postal Code
02914
Country
United States
Facility Name
Furiex Research Site
City
Anderson
State/Province
South Carolina
ZIP/Postal Code
29621
Country
United States
Facility Name
Furiex Research Site
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29406
Country
United States
Facility Name
Furiex Research Site
City
Fort Mill
State/Province
South Carolina
ZIP/Postal Code
29707
Country
United States
Facility Name
Furiex Research Site
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29615
Country
United States
Facility Name
Furiex Research Site
City
Greer
State/Province
South Carolina
ZIP/Postal Code
29650
Country
United States
Facility Name
Furiex Research Site
City
Greer
State/Province
South Carolina
ZIP/Postal Code
29651
Country
United States
Facility Name
Furiex Research Site
City
Myrtle Beach
State/Province
South Carolina
ZIP/Postal Code
29588
Country
United States
Facility Name
Furiex Research Site
City
Myrtle Beach
State/Province
South Carolina
ZIP/Postal Code
29752
Country
United States
Facility Name
Furiex Research Site
City
Simpsonville
State/Province
South Carolina
ZIP/Postal Code
29681
Country
United States
Facility Name
Furiex Research Site
City
Summerville
State/Province
South Carolina
ZIP/Postal Code
29485
Country
United States
Facility Name
Furiex Research Site
City
Bristol
State/Province
Tennessee
ZIP/Postal Code
37620
Country
United States
Facility Name
Furiex Research Site
City
Chattanooga
State/Province
Tennessee
ZIP/Postal Code
37421
Country
United States
Facility Name
Furiex Research Site
City
Clarksville
State/Province
Tennessee
ZIP/Postal Code
37043
Country
United States
Facility Name
Furiex Research Site
City
Columbia
State/Province
Tennessee
ZIP/Postal Code
38401
Country
United States
Facility Name
Furiex Research Site
City
Franklin
State/Province
Tennessee
ZIP/Postal Code
37064
Country
United States
Facility Name
Furiex Research Site
City
Johnson City
State/Province
Tennessee
ZIP/Postal Code
37604
Country
United States
Facility Name
Furiex Research Site
City
Memphis
State/Province
Tennessee
ZIP/Postal Code
38119
Country
United States
Facility Name
Furiex Research Site
City
Smyrna
State/Province
Tennessee
ZIP/Postal Code
37167
Country
United States
Facility Name
Furiex Research Site
City
Austin
State/Province
Texas
ZIP/Postal Code
78745
Country
United States
Facility Name
Furiex Research Site
City
Austin
State/Province
Texas
ZIP/Postal Code
78756
Country
United States
Facility Name
Furiex Research Site
City
Baytown
State/Province
Texas
ZIP/Postal Code
77521
Country
United States
Facility Name
Furiex Research Site
City
Beaumont
State/Province
Texas
ZIP/Postal Code
77701
Country
United States
Facility Name
Furiex Research Site
City
Dallas
State/Province
Texas
ZIP/Postal Code
75224
Country
United States
Facility Name
Furiex Research Site
City
El Paso
State/Province
Texas
ZIP/Postal Code
79905
Country
United States
Facility Name
Furiex Research Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77074
Country
United States
Facility Name
Furiex Research Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77079
Country
United States
Facility Name
Furiex Research Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77089
Country
United States
Facility Name
Furiex Research Site
City
Houston
State/Province
Texas
ZIP/Postal Code
77098
Country
United States
Facility Name
Furiex Research Site
City
Marshall
State/Province
Texas
ZIP/Postal Code
75670
Country
United States
Facility Name
Furiex Research Site
City
Plano
State/Province
Texas
ZIP/Postal Code
75024
Country
United States
Facility Name
Furiex Research Site
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78209
Country
United States
Facility Name
Furiex Research Site
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Facility Name
Furiex Research Site
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78258
Country
United States
Facility Name
Furiex Research Site
City
Sugar Land
State/Province
Texas
ZIP/Postal Code
77478
Country
United States
Facility Name
Furiex Research Site
City
Clinton
State/Province
Utah
ZIP/Postal Code
84015
Country
United States
Facility Name
Furiex Research Site
City
Draper
State/Province
Utah
ZIP/Postal Code
84020
Country
United States
Facility Name
Furiex Research Site
City
Logan
State/Province
Utah
ZIP/Postal Code
84341
Country
United States
Facility Name
Furiex Research Site
City
Ogden
State/Province
Utah
ZIP/Postal Code
84405
Country
United States
Facility Name
Furiex Research Site
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84102
Country
United States
Facility Name
Furiex Research Site
City
West Jordan
State/Province
Utah
ZIP/Postal Code
84088
Country
United States
Facility Name
Furiex Research Site
City
Lynchburg
State/Province
Virginia
ZIP/Postal Code
24502
Country
United States
Facility Name
Furiex Research Site
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23219
Country
United States
Facility Name
Furiex Research Site
City
Williamsburg
State/Province
Virginia
ZIP/Postal Code
23185
Country
United States
Facility Name
Furiex Research Site
City
Spokane
State/Province
Washington
ZIP/Postal Code
99202
Country
United States
Facility Name
Furiex Research Site
City
Spokane
State/Province
Washington
ZIP/Postal Code
99204
Country
United States
Facility Name
Furiex Research Site
City
Spokane
State/Province
Washington
ZIP/Postal Code
99208
Country
United States
Facility Name
Furiex Research Site
City
Wenatchee
State/Province
Washington
ZIP/Postal Code
98801
Country
United States
Facility Name
Furiex Research Site
City
Morgantown
State/Province
West Virginia
ZIP/Postal Code
26505
Country
United States
Facility Name
Furiex Research Site
City
Wauwatosa
State/Province
Wisconsin
ZIP/Postal Code
53226
Country
United States
Facility Name
Furiex Research Site
City
Kamloops
State/Province
British Columbia
ZIP/Postal Code
V2C 1K7
Country
Canada
Facility Name
Furiex Research Site
City
Kelowna
State/Province
British Columbia
ZIP/Postal Code
V1Y 1Z9
Country
Canada
Facility Name
Furiex Research Site
City
Winnipeg
State/Province
Manitoba
ZIP/Postal Code
R3A 1R9
Country
Canada
Facility Name
Furiex Research Site
City
Bridgewater
State/Province
Nova Scotia
ZIP/Postal Code
B4V 3N2
Country
Canada
Facility Name
Furiex Research Site
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3K 2M5
Country
Canada
Facility Name
Furiex Research Site
City
Cambridge
State/Province
Ontario
ZIP/Postal Code
N1S 2M6
Country
Canada
Facility Name
Furiex Research Site
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 5R8
Country
Canada
Facility Name
Furiex Research Site
City
Niagara Falls
State/Province
Ontario
ZIP/Postal Code
L2G 1J4
Country
Canada
Facility Name
Furiex Research Site
City
Oshawa
State/Province
Ontario
ZIP/Postal Code
L1H 1B9
Country
Canada
Facility Name
Furiex Research Site
City
Chesterfield
State/Province
Derbyshire
ZIP/Postal Code
S40 4AA
Country
United Kingdom
Facility Name
Furiex Research Site
City
Blackpool
State/Province
Lancashire
ZIP/Postal Code
FY3 7EN
Country
United Kingdom
Facility Name
Furiex Research Site
City
Thornton-Cleveleys
State/Province
Lancashire
ZIP/Postal Code
FY5 3LF
Country
United Kingdom
Facility Name
Furiex Research Site
City
Burbage
State/Province
Leicestershire
ZIP/Postal Code
LE10 2SE
Country
United Kingdom
Facility Name
Furiex Research Site
City
Leamington Spa
State/Province
Warwickshire
ZIP/Postal Code
CV32 4RA
Country
United Kingdom
Facility Name
Furiex Research Site
City
Chippenham
State/Province
Wiltshire
ZIP/Postal Code
SN14 6GT
Country
United Kingdom
Facility Name
Furiex Research Site
City
Bath
ZIP/Postal Code
BA2 3HT
Country
United Kingdom
Facility Name
Furiex Research Site
City
Bath
ZIP/Postal Code
BA2 4BY
Country
United Kingdom
Facility Name
Furiex Research Site
City
Coventry
ZIP/Postal Code
CV6 4DD
Country
United Kingdom
Facility Name
Furiex Research Site
City
Dorking
ZIP/Postal Code
RH4 1SD
Country
United Kingdom
Facility Name
Furiex Research Site
City
Haxey
ZIP/Postal Code
DN9 2HY
Country
United Kingdom
Facility Name
Furiex Research Site
City
London
ZIP/Postal Code
E11 1NR
Country
United Kingdom
Facility Name
Furiex Research Site
City
Shrewsbury
ZIP/Postal Code
SY3 8XQ
Country
United Kingdom
Facility Name
Furiex Research Site
City
Southampton
ZIP/Postal Code
SO16 6YD
Country
United Kingdom
Facility Name
Furiex Research Site
City
Strensall
ZIP/Postal Code
YO32 5UA
Country
United Kingdom
Facility Name
Furiex Research Site
City
Thornton
ZIP/Postal Code
FY5 2TZ
Country
United Kingdom
Facility Name
Furiex Research Site
City
Torpoint
ZIP/Postal Code
PL11 2JW
Country
United Kingdom

12. IPD Sharing Statement

Citations:
PubMed Identifier
28167156
Citation
Fant RV, Henningfield JE, Cash BD, Dove LS, Covington PS. Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea. Clin Gastroenterol Hepatol. 2017 Jul;15(7):1021-1029.e6. doi: 10.1016/j.cgh.2017.01.026. Epub 2017 Feb 3.
Results Reference
derived
PubMed Identifier
26789872
Citation
Lembo AJ, Lacy BE, Zuckerman MJ, Schey R, Dove LS, Andrae DA, Davenport JM, McIntyre G, Lopez R, Turner L, Covington PS. Eluxadoline for Irritable Bowel Syndrome with Diarrhea. N Engl J Med. 2016 Jan 21;374(3):242-53. doi: 10.1056/NEJMoa1505180.
Results Reference
derived

Learn more about this trial

Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d)

We'll reach out to this number within 24 hrs